ANI Pharmaceuticals (BSFA) Revenue
ANI Pharmaceuticals Revenue
ANI Pharmaceuticals had a revenue of 266.04M in the quarter ending Jun 30, 2026, with 12.04%. This bring the company's revenue in the last twelve months to 978.38M, Increased 5.92%. In the fiscal year ending Dec 31, 2025, ANI Pharmaceuticals had annual revenue of 883.37M with 43.78% growth.
- Revenue (ttm)
- 978.38M
- Revenue Growth
- 22.04%
- P/S Ratio
- 1.67
- Revenue/Employee
- EUR 910,687
- Employees
- 970
- Market Cap
- EUR 1.48B
Revenue Chart
ANI Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 883.37M | 268.99M | 43.78% |
| Dec 31, 2024 | 614.38M | 127.56M | 26.20% |
| Dec 31, 2023 | 486.82M | 170.43M | 53.87% |
| Dec 31, 2022 | 316.38M | 100.25M | 46.38% |
| Dec 31, 2021 | 216.14M | 7.66M | 3.67% |
| Dec 31, 2020 | 208.47M | 1.93M | 0.93% |
| Dec 31, 2019 | 206.55M | 4.97M | 2.47% |
| Dec 31, 2018 | 201.58M | 24.73M | 13.99% |
| Dec 31, 2017 | 176.84M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.